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The Role of Reactive Oxygen Species in Pressure-Dependent Myogenic Tone
 (Peranan Spesis Oksigen Reaktif dalam Tonus Miogenik yang Bergantung dengan Tekanan)
SATIRAH ZAINALABIDIN, PAUL COATS & ROGER M. WADSWORTH
ABSTRACT
Myogenic tone is the response of the vascular smooth muscle to an increase in intraluminal pressure with vasoconstriction 
and with vasodilation when the pressure is decreased. Such myogenic tone contributes a level of physiological basal 
tone in response to neurohumoral stimuli. In spite of myogenic tone discovery by Sir William Bayliss 100 years ago, 
questions still remain regarding the underlying signaling mechanism of the myogenic response. Studies have shown that 
increased intraluminal pressure or wall tension leads to membrane depolarization, voltage-operated calcium channel 
(VOCC), stretch-activated cation (SAC) channels, extracelullar matrix (ECM) and actin cytoskeleton. Recently, evidence 
has shown a potential role for reactive oxygen species (ROS) as a key signalling mediator in the genesis of myogenic tone. 
The identification of the primary mechanosensors in the initiation of pressure-dependent myogenic tone is essential as 
these components could be potential therapeutical targets in the future.
Keywords: Microcirculation, ROS, myogenic tone  
ABSTRAK
Tonus miogenik adalah respon vasokonstriksi otot licin vaskular ke atas peningkatan tekanan intralumina dan 
respon vasodilatasi pula ke atas penurunan tekanan intralumina. Kompensasi tonus miogenik menyumbang kepada 
pengawalaturan tonus basal dalam keadaan fisiologi terhadap rangsangan neurohormon. Walaupun Sir William Bayliss 
telah menemui tonus miogenik pada 100 tahun yang lalu, namun mekanisme signal di sebalik respons miogenik masih 
belum dikenal pasti  secara mendalam. Kajian lepas telah menunjukkan bahawa peningkatan tekanan intralumina ataupun 
ketegangan dinding vaskular menyebabkan depolarisasi membran, rangsangan kanal kalsium voltan-tergantung, kation 
ketegangan-terangsang, matrik ekstraselular dan sitoskeleton aktin. Bukti telah menunjukkan potensi sepsis oksigen 
reaktif (ROS) sebagai perantara signal semasa mekanisme tonus miogenik. Pengenalpastian dan pemahaman mengenai 
mekanosensor primary yang merangsang permulaan tonus miogenik bergantung-tekanan adalah penting sebagai potensi 
terapeutik di masa hadapan. 
Kata kunci: Mikrosirkulasi, ROS, tonus miogenik
AUTOREGULATION IN RESISTANCE ARTERIES
In the cardiovascular system, blood vessel function is 
related to its structure. Specifically, major arteries of 
the trunk are the elastic conductance arteries with large 
diameter and low resistance. On the contrary, distal arteries 
are muscular arteries of small diameter and high resistance 
that are critical for blood flow or pressure within the 
microcirculation system. Under physiological conditions, 
the viscoelasticity of the large arteries results in pulsatile 
pressure and flow so that the microvasculature can mediate 
blood supply steadily. The microvessels proximal to the 
arterioles with lumen diameter less than 200 μm were 
defined by Mulvany and Aalkjaer (1990) as the vessels 
offering the greatest resistance. The resistance value can 
vary depending for the entire vascular system, for the 
vascular network in selected organs and for individual 
vessels (Zweifach 1991), therefore, the size of resistance 
arteries may vary and be more than 200 μm diameter. 
Resistance arteries have the ability to alter their diameter 
independent of neural and hormonal control, in order 
to keep a relatively constant blood flow. The efficiency 
of autoregulation varies from tissue to tissue with those 
organs most vital for survival, e.g. brain, heart, kidney, 
demonstrating the most marked autoregulatory capacity. 
A number of local intrinsic control mechanisms have been 
proposed to account for the homeostatic properties of 
autoregulation, which are the combination of metabolites 
such as lactate and adenosine, flow-dependent regulation 
and myogenic tone (Hill et al. 2006; Henrion 2005). 
Pressure-dependent myogenic tone in small resistance 
arteries is defined as the intrinsic property of vascular 
smooth muscle (VSM) cells to respond to changes in 
transmural pressure. Sir William Bayliss was the first to 
discover myogenic tone in 1902 when he recorded large 
increases in the volume of a dog’s hind limb following the 
release of brief aortic occlusion (Bayliss 1902). Bayliss 
considered the blood volume increase response too rapid to 
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2be mediated by accumulation of metabolites and concluded 
that a significant component of vascular tone could be 
modulated by changes in intravascular pressure. Bjorn 
Folkow (1949) supported Bayliss’s theory demonstrating 
that denervated preparations of blood vessels developed 
pressure-dependent vascular tone and autoregulation of 
blood flow was neurohormonal-independent (Folkow 
1949). However, in spite of more than 100 years of 
myogenic tone study, the knowledge of the exact primary 
sensors to the signalling mechanisms that allow changes 
of intraluminal pressure to be converted accordingly into 
appropriate arterial diameter, remain incomplete and 
controversial. This has been a key challenge and a true 
understanding of the underlying mechanism is important 
in order to tackle the treatment of the pathological states. 
PRESSURE-DEPENDENT MYOGENIC TONE 
MECHANISMS
Myogenic tone shows an inverse relationship between 
pressure and diameter, where an increase of intraluminal 
pressure causes a decrease in diameter, and vice versa. 
Moreover, the strength of the myogenic response varies 
depending on the diameter and the particular vascular 
bed. In the hamster cheek pouch, relative myogenic 
responsiveness increased with decreasing vessel size in 
second- and third-order arterioles, whereas fourth-order 
arterioles were substantially less responsive than third-
order arterioles (Davis 1993). Relative myogenic tone 
varies between different vascular beds, with rat cerebral 
(Gokina et al. 2005) and skeletal muscle vessels (Coats 
2010) exhibiting more prominent myogenic response than 
small mesenteric vessels (Chin et al. 2007). Differences 
in the strength of the myogenic response between vessels 
with similar diameter have also been observed within 
the network of a vascular bed. For example, there was a 
weak myogenic response in subendocardial but a strong 
myogenic response in subepicardial porcine arteries (Kuo 
et al. 1988). 
According to the reviews by Hill et al. (2006) and 
Khavandi et al. (2009), myogenic behaviour can be divided 
into three phases. The first consists of myogenic or basal 
tone development, associated with a large increase in 
L-type VOCC-mediated membrane depolarization and 
[Ca2+]i. The second phase is known as myogenic reactivity, 
where further constriction happens in response to an 
increase in intraluminal pressure. The [Ca2+]i concentration 
is maintained at this phase, but [Ca2+]i sensitization of 
the mechanical apparatus is thought to occur. The third 
phase is called forced dilation, when the wall of the artery 
is unable to maintain a constriction against mounting 
pressure. There are a number of candidates that could 
be mediating myogenic response, however there is no 
agreement on whether it is the vessel wall tension (Davis 
et al. 1992, Dunn & Gardiner 1997, Brekke et al. 2002), 
stretch-activated cation (SAC) channels (Davis et al. 
1992), VOCC (McCarron et al. 1997), extracelullar matrix 
(ECM) (Davis et al. 2001) or actin cytoskeleton (Cipolla 
et al. 2002). Knowledge about the cellular mechanisms 
underlying myogenic tone is important and could be 
exploited for therapeutic intervention, as myogenic 
responsiveness is commonly altered in vascular diseases. 
Therefore, it is crucial to understand the stimuli, sensor, 
signal transduction pathways involving second messengers, 
regulation of contractile proteins and finally the adjustment 
for vasomotor tone. 
ION CHANNELS
Putative plasma membrane ion channels functioning as 
primary mechanosensors in mediating arteriolar myogenic 
vasoconstriction include VOCC (Kotecha & Hill 2005; Knot 
& Nelson 1998), SAC (Luchessi et al. 2004), TRPC (Mederos 
y Schnitzler et al. 2008), large conductance Ca2+-activated 
K+ channel (BKCa) (Dong et al. 2009; Cheranov & Jaggar 
2006), voltage-gated potassium channel (Kv) (Sobey et 
al. 1998) and Ca2+-activated chloride channels (ClCa) 
(Dimitropoulou et al. 2001).
A plethora of evidence has shown that the pressure-
dependent myogenic response is mediated by an increase of 
membrane depolarization and [Ca2+]i in VSM, accompanied 
by the classical Ca2+-calmodulin–induced myosin light 
chain (MLC) phosphorylation (Harder 1984; Davis & 
Hill 1999; Hill et al. 2001; Schubert et al. 2008). The 
pioneering study by Harder (1984) was the first to show 
that an increase in pressure caused depolarization and 
therefore an increase in Ca2+ influx and vasoconstriction, 
within the cerebral artery. A subsequent study showed 
that the increased Ca2+ influx occurred in parallel with the 
decrease in diameter (Knot & Nelson 1998). Incubation in 
a Ca2+-free solution or the administration of the Ca2+-entry 
blocker diltiazem, led to a complete loss of myogenic 
tone (Bevan 1982). The Ca2+ influx has been shown to 
depend primarily on L-type VOCC which can be inhibited 
by nifedipine (Kotecha & Hill 2005; Coats et al. 2001; 
Scotland et al. 2004; VanBavel et al. 1998). 
The primary events that lead to an increase of 
[Ca2+]i are the release of Ca
2+ from intracellular stores 
and transmembrane influx. However, a study found the 
internal ryanodine-sensitive Ca2+ store to be insignificant 
in myogenic constriction, indicating that CICR is a minor 
contributor to the response (McCarron et al. 1997). 
Recently, extracellular Ca2+ has been reviewed by 
Smajilovic and Tfelt-Hansen (2007) for eliciting the 
role as a first messenger through a G-protein coupled 
receptor (GPCR), namely the Ca2+-sensing receptor (CaR). 
In subcutaneous arteries, the CaR was found to modulate 
pressure-dependent myogenic tone, while PKC was acting 
as its negative regulator (Ohanian et al. 2005). However, 
the CaR paradigm is relatively new in the area of myogenic 
tone and more investigation is needed to clarify its 
function. Another recent study that supports GCPR as a 
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3mechanosensor is where Gq/11-coupled receptor, a GCPR, 
was activated and stimulated β-arrestin recruitment in 
response to increased pressure (Mederos y Schnitzler et al. 
2008). Subsequently, this process lead to TRPC-mediated 
membrane depolarization and enhanced myogenic 
constriction in renal and cerebral arteries.
Although Ca2+ has been shown as a necessary key 
signalling component in myogenic constriction, some 
studies have shown that only a minimal rise in [Ca2+]i is 
required to elicit myogenic constriction (D’Angelo et al. 
1997; VanBavel et al. 1998). Therefore, Ca2+ is not the 
only determinant of steady-state constriction and there 
are Ca2+-independent regulatory systems involving protein 
kinase C (PKC), Rho/Rho kinase, protein tyrosine kinase 
and cytoskeleton, that accompany myogenic constriction 
(Lagaud et al. 2002; Gokina et al. 2005; Massett et al. 2002; 
Jarajapu & Knot 2002). 
INTRACELLULAR SECOND MESSENGERS
There has been a growing body of evidence that shows 
Ca2+ sensitivity regulation integrates with Ca2+-independent 
mechanisms in the myogenic constriction, via intracellular 
second messengers signalling in VSM. Pressure or stretch 
acts as the stimulus for G proteins, which then stimulate the 
membrane enzyme phospholipase C (PLC) that specifically 
hydrolyzes phosphatidylinositol-4,5-biphosphate (PIP2). 
PIP2 is split into two second messengers, diacylglycerol 
(DAG) and inotisol-1,4,5-triphosphate (IP
3
) (Narayanan et al. 
1994). Both IP
3 and DAG have been shown to increase with 
the level of intraluminal pressure and to remain elevated 
for the duration of the pressure increase (Narayanan et al. 
1994). The increase in the level of intracellular IP
3
, induced 
by stretch, may be responsible for part of the pressure-
induced increase of [Ca2+]i (Jarajapu & Knot 2002). The 
increase in DAG, which is an activator of protein kinase C 
(PKC), implicates the participation of PKC in the myogenic 
response (Gokina et al. 1999; Wesselman et al. 2001). 
Indeed, the PKC activator, phorbol-12,13-dibutyrate (PDBu) 
was found to increase the level of Ca2+, and this effect was 
abolished by nifedipine, an L-type Ca2+ channel blocker 
(Lin et al. 1998; Ohanian et al. 2005). This suggests 
that the PKC-enhancing effect by PDBu was through the 
activation of L-type Ca2+ channels and this could increase 
Ca2+ sensitivity resulting in myogenic constriction (Lin 
et al. 1998; Gokina et al. 1999). Consistent with the 
fact that PKC phosphorylates mitogen-activated protein 
kinase (MAPK), it has been shown that inhibition of MAPK 
reduced the Ca2+ sensitivity and hence, attenuated the 
pressure-dependent myogenic tone (Massett et al. 2002; 
Lagaud et al. 1999). Another potential pathway regulating 
myogenic tone is the RhoA/Rho kinase signaling pathway. 
Results have shown that RhoA/Rho kinase pathway to be 
activated by mechanical stretch, leading to an increase in 
intracellular [Ca2+] sensitivity. This could potentially inhibit 
myosin phosphatase and/or activate actin cytoskeleton 
polymerization, followed by increased myogenic tone 
(Gokina et al. 2005; Jarajapu & Knot 2005). Another 
interesting key candidate in modulating myogenic tone 
is the epidermal growth factor receptor (EGFR). A study 
in mesenteric arteries has shown pressure/stretch to 
stimulate metalloproteinases 2/9 (MMP-2/9), leading to 
endogenous HB-EGF (heparin-binding EGF-like growth 
factor) release and EGFR transactivation (Lucchesi et al. 
2004). This mechanism was specific to myogenic tone as 
contractions to ANG II and KCl were independent of EGFR 
transactivation. The underlying mechanism within the VSM 
was not investigated, but it was speculated that MMP-2/9 
activation may involve integrins (Belmadani et al. 2008) or 
SACs (Scotland et al. 2004), and the downstream signalling 
of EGFR activation may be PKC-dependent (Jarajapu & Knot 
2005) or through Nox/ROS (Csanyi et al. 2009). 
CyTOCHROMe P-450
The cytochrome P-450 (CYP) enzymes metabolize 
endogenous arachidonic acid (AA) and are referred to 
as the third pathway of AA metabolism, the others being 
cyclooxygenases and lipooxygenases. The role of CYP has 
been reviewed as a candidate mediator in signaling events 
culminating in pressure-dependent myogenic tone in renal, 
skeletal muscle and pulmonary arteries (Terashvili et al. 
2006; Frisbee et al. 2001; Kaley 2000; Parker et al. 2005). 
Phospholipase A2 (PLA2) is an enzyme which hydrolyzes 
phospholipids and produces AA. This AA can be further 
metabolized to produce autocrine vasoconstrictor 20-HETE 
(20-hydroxyeicosatetraenoic acid) and vasodilator 11,12-
EET (11,12-epoxyeicosatrienoic acid), which could enhance 
ROS release. Stimulation of VSM cells by stretch, pressure 
and flow could trigger CYP to release 20-HETE, which 
inhibits the opening of Ca2+-activated K+ (KCa) channels 
in VSM, causing depolarization, and eventually increases 
Ca2+ entry and promotes myogenic constriction (Frisbee et 
al. 2001). As for 11,12-EET, it exhibits biological activities 
opposite to 20-HETE; where it vasodilates blood vessels and 
stimulates hyperpolarization via KCa channels in VSM cells 
(Imig 1999). Hence, the dual counterbalancing activity of 
these two AA metabolites may present a mechanism for 
balanced regulation of myogenic tone regulation.
REACTIVE OxYGEN SPECIES
Reactive oxygen species and oxidative stress have been 
synonymous in pathological conditions for decades. 
Recently, a growing body of evidence has shown that 
ROS could play a role in regulating pressure-dependent 
myogenic tone (Lecarpentier 2007; Keller et al. 2006). 
Besides ROS, another emerging new candidate is the 
actin cytoskeleton (Faraci 2006). Figure 1 summarizes 
the overall putative mechanotransduction pathways of 
pressure-dependent myogenic tone regulation. 
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4REACTIVE OxYGEN SPECIES IN 
CARDIOVASCULAR HEALTH  
AND DISEASES
REACTIVE OxYGEN SPECIES AND OxIDATIVE STRESS
ROS are classically considered as a toxic by-product of 
metabolism in oxidative stress (Taniyama & Griendling 
2003; Dworakowski et al. 2006). When ROS is produced 
excessively, overwhelming of endogenous antioxidant 
systems and/or during downregulation of antioxidant 
systems, oxidative stress occurs (Griendling & Fitzgerald 
2003; Taniyama & Griendling 2003; Dworakowski et al. 
2006). Dysregulation due to oxidative stress has been 
shown to contribute substantially to the progression of 
cardiovascular diseases such as hypertension (Schiffrin 
2004; Intengan et al. 1999), diabetes (Sachidanandam 
et al. 2007), hypercholesterolaemia (Ishikawa et al. 2004), 
cardiac hypertrophy (Lang 2002) and myocardial ischaemia 
(Ferrari et al. 2004). 
The term ‘oxidative stress’ may be an over-
simplification as it is used to cover the diverse and complex 
role of ROS in physiological and pathophysiological 
conditions. Over the past decade, studies have shown 
that ROS at relatively low cellular levels may influence 
metabolism in physiological conditions (Lecarpentier 
2007; Keller et al. 2006) and may be involved with the 
normal regulation of vascular tone and structure (Faraci 
FIGURE 1. Overview of possible pathways involved in the myogenic response. The possible pathways may involve 
ion channels, intracellular second messengers, cytochrome P450 and the newly  arised new candidates, ROS and actin 
cytoskeleton. PIP2 (phosphatidylinositol (4,5)-bisphosphate); PLC (phospholipase C); IP3 (inositol trisphosphate); DAG 
(diacylglycerol); PKC (protein kinase C); VOCC (voltage-operated calcium channel); PLA2 (phospholipase A2); 20-HETE 
(20-hydroxyeicosatetraenoic acid); KCa (calcium-activated potassium channel); Ca2+ (calcium); CaM (calmodulin); 
MLCK (myosin light-chain kinase); myosin-P (myosin-phosphate); SR (sarcoplamic reticulum)
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52006). ROS may have direct and indirect effects on VSM, 
and there are studies suggesting that both relaxation and 
contraction of vascular muscle may occur, depending on 
the tissue model and the physiological circumstances.
METABOLISM OF ROS
ROS includes free radicals such as superoxide anion (O2
–) 
and hydroxyl radical (OH–), and nonradical species such 
as hydrogen peroxide (H2O2) (Hamilton et al. 2004). 
Superoxide dismutase (SOD) metabolizes O2
– to H2O2. There 
are three isoforms for SOD: CuZn-containing cytosolic 
SOD1, Mn-containing SOD2 and CuZn-containing 
extracellular SOD3. Peroxidases such as catalase and 
glutathione peroxidase further metabolize H2O2 to O2 and 
water. H2O2 can also be transformed to OH
– and O2
– to 
peroxynitrite (ONOO–) (Faraci 2006; Miller et al. 2006; 
Hamilton et al. 2004). Almost all types of vascular cell 
produce O2
– and H2O2 (Lyle & Griendling 2005). Primarily, 
ROS within a blood vessel is produced by the membrane-
bound enzyme Nox (Griendling et al. 1994), but ROS has 
been shown to also be produced from adventitial fibroblasts 
(Pagano et al. 1997), cyclooxygenase (Sobey et al. 1998; 
Miller et al. 2006) as well as eNOS (Matoba et al. 2000). 
There are many stimuli which activate Nox, including 
ANG II (Mehta and Griendling, 2007), ET-1 (An et al. 
2007), shear stress (Hwang et al. 2003), tumor necrosis 
factor-α (TNF-α) (Al-Mehdi and Fisher 1998), metabolic 
factors including hyperglycaemia, insulin (Dworakowski 
et al. 2006), hypercholesterolemia (Ishikawa et al. 2004), 
and vascular endothelial growth factor (VEGF) (Abid 
et al. 2007). 
O2
– is highly reactive, but it has a very short half-life 
and poor cell permeability. Therefore, the impact of O2
– 
on vascular function could be instant but short-lasting. 
The reaction of O2
– with EDNO is very rapid, 3 times 
faster than the dismutation of O2
–, resulting in reduced 
NO bioavailability and increased ONOO-. Conversely, 
H2O2 is relatively stable and highly diffusible between 
cells. Therefore, H2O2 is regarded as one of the most 
important ROS molecules for modulating vascular function. 
It has been reported as an EDHF in the mesenteric artery 
(Matoba et al. 2000) and partially mediates flow-dependent 
vasodilatation in coronary arterioles (Miura et al. 2003). 
Figure 2 shows the general metabolism of ROS and the 
associated complications in cardiovascular diseases.
 H2O2  
FIGURE 2. Generation of O2
– and H2O2 from O2 in vascular tissue and the associated 
complications in cardiovascular diseases. GSSG, oxidized glutathione; GSH, reduced 
glutathione; SOD, superoxide dismutase; ONOO-, peroxynitrite; NO, nitric oxide; VSM, 
vascular smooth muscle; EC, endothelial cells
Atherosclerosis, Inflammation, Thrombosis, Fibrosis
Hypertension, Diabetes mellitus, Restenosis, Stroke, 
Peripheral Vascular Disease, Myocardial Infarction
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6NADPH OxIDASE SUBUNITS
The Nox in the vasculature consists of p22phox, p47phox and 
novel homologues of gp91phox, which are NOx1, NOx2 and 
NOx4 (Seshiah et al. 2002; Cave 2008). These isoforms 
are different between cell types and they have separate 
locations within the cell. The evidence is becoming 
increasingly clear that the individual Nox isoforms have 
delineated roles within the cell and are linked with specific 
downstream effects (Cave et al. 2005; Cave 2008). 
ANG II AS AN NADPH OxIDASE/ ROS ACTIVATOR
ANG II stimulates Nox and ROS activity in all cells within 
the vascular wall (Griendling & Ushio-Fukai 2000; 
Pedruzzi et al. 2004; Gonzalez et al. 2008). ANG II not only 
stimulates Nox-dependent O2
– formation in VSM cells but 
also in cardiac, endothelial, mesangial cells and adventitial 
fibroblasts (Zhang et al. 1999; Pedruzzi et al. 2004; Mehta 
& Griendling 2007). In rabbit aortic adventitial fibroblasts, 
induction of Nox subunit p67phox expression was caused 
by ANG II-induced O2
– (Pagano et al. 1998). In rat VSM, 
subunit p22phox has been shown to be a component in the 
ANG II-induced hypertrophy (Ushio-Fukai et al. 1996). 
A member of a new family of gp91phox, NOx1, showed a 
role in mediating ANG II-induced O2
– formation via redox 
signalling in VSM cells (Lassegue et al. 2001). Angiotensin 
AT1 receptors (AT1R) are believed to be mainly located 
in the VSM cells and to induce vasoconstriction (Maeso 
et al. 1996; Touyz & Schiffrin 2000), while angiotensin 
AT2 receptors (AT2R) mediate endothelium-dependent 
vasodilation (Carey et al. 2000). 
In addition to stimulating Nox to release ROS, ANG 
II has also been found to stimulate various downstream 
signalling pathways in relation to pressure-dependent 
myogenic tone. For instance, intraluminal pressure 
facilitated by ANG II may activate AT1R which in turn causes 
transactivation of the platelet-derived growth factor (PDGF), 
then through the Ras-Raf pathway activates extracellular 
signal-regulated kinase 1/2 (ERK1/2) (Matrougui et al. 
2000, eskildsen-Helmond & Mulvany 2003). However, 
how the mechanical loading can cause such acute and 
rapid activation is still unknown. Suggested pathways 
may include the PLC-IP
3
 pathway resulting in increase of 
[Ca2+]i and Ca
2+-dependent ERK1/2 stimulation, or the PLC-
DAG pathway whereby PKC can activate ERK1/2 (Eskildsen-
Helmond & Mulvany 2003). Other interesting supporting 
findings were that AT1R stimulation could initiate G-to-F 
actin and strengthen the cytoskeletal structure (Martinez-
Lemus 2008) or it could activate TRPC-mediated membrane 
depolarization and cause myogenic tone (Mederos y 
Schnitzler et al. 2008).
ROS IN THE BIOLOGY OF VASCULAR TONE
The first direct evidence that endogenous ROS can act 
as a signalling molecule was found by Kontos et al. 
(1984). Their study found that dilation by topical sodium 
arachidonate and bradykinin was inhibited by catalase and 
SOD in cat cerebral artery. Thus, O2
– and H2O2 or radical 
derivatives such as OH– were likely to be the mediators 
from sodium arachidonate and bradykinin that caused 
vasodilation. Since then, a growing body of evidence has 
demonstrated ROS as potent intracellular and intercellular 
second messengers to modulate many downstream 
signalling molecules via [Ca2+]i-dependent and [Ca
2+]i 
-independent pathways and eventually cause substantial 
interplay in myogenic response. 
The major effect of O2
– was thought to be peripheral 
vasocontraction by its reaction with EDNO, as shown widely 
in oxidative stress. It is now known that in cerebral arteries, 
O2
– can cause both constriction and dilation (Wei et al. 
1996; Didion & Faraci 2002). The K+ channel blocker, 
tetraethylammonium (TEA), reduced cerebral relaxation 
to O2
–, suggesting that KCa channels are involved (Wei 
et al. 1996). H2O2 has also been shown to induce both 
vasorelaxation and vasoconstriction, depending on the 
vascular bed and the pre-constrictor agent. H2O2 from the 
endothelium may act as a vasodilatory EDHF in murine 
(Kimura et al. 2002), human mesenteric arteries (Matoba 
et al. 2002) and human coronary arterioles (Miura et al. 
2003). At higher concentration (>1 mM), H2O2 has been 
found to cause vasoconstriction followed by vasodilatation 
(Miller et al. 2005). Dilatation of rat cerebral arterioles in 
response to exogenous H2O2, or endogenous bradykinin-
derived H2O2 is mediated by activation of KCa channels 
(Sobey et al. 1997). In other studies, mitochondrial-derived 
ROS dilated cerebral arteries by increasing KCa channel 
activity via Ca2+ sparks (xi et al. 2005), whereas H2O2 
dilated cerebral arterioles by activating ATP-sensitive K+ 
channels (Wei et al. 1996). Thus, activation of K+ channels 
may be a major mechanism of dilatation in response to 
H2O2 in the microcirculation. In a study on canine basilar 
arteries, different types of exogenous ROS elicit different 
characteristics of contraction, whereby H2O2 showed the 
fast onset and a transient contraction, O2
– showed slow 
onset and a transient contraction, and OH– showed a 
sustained contraction (Tosaka et al. 2002). This shows 
the importance of identifying the types of radical and 
nonradical species in the pathological mechanisms as each 
ROS could play a different role. 
ROS 
From the study of ROS in cultured cells to vascular tone, 
the interest of its role in modulating pressure-dependent 
myogenic tone has been growing. Exogenous H2O2 was 
found to increase myogenic tone in tail arterioles (Nowicki 
et al. 2001) and mesenteric arteries (Lucchesi et al. 2005). 
In addition, endogenous ROS (H2O2) was produced from 
Nox after dipheleneiodonium (DPI) and N-acetylcysteine 
(NAC) treatment, and mice lacking rac1 and p47phox showed 
inhibited myogenic tone (Nowicki et al. 2001). Another 
supporting study showed myogenic tone was dependent 
on mitochondria-derived ROS (H2O2) during cold (28°C), 
JSKM bab 1.indd   6 8/3/2012   2:41:26 PM
7which stimulated RhoA/Rho kinase signalling and smooth 
muscle α2C-adrenoceptors, a mechanism that could be 
relevant to Raynaud’s pathophysiology (Bailey et al. 
2005). Although H2O2 caused constriction in the study, 
other studies showed that it could also act as a vasodilator 
(EDHF) (Miura et al. 2003; Matoba et al. 2002; Drouin et 
al. 2007). The dual effects of H2O2 were also observed in a 
study by Luchessi et al. (2005) where low concentrations of 
exogenous H2O2 caused vasodilation when the K
+ channel 
was compromised by KCl, and the opposite effect was 
seen when KCl was removed in pressurized mesenteric 
arteries. H2O2 also exhibits a biphasic effect, causing 
vasoconstriction at low concentrations and vasodilation 
at high concentrations, also possibly mediated via K+ 
channels (Cseko et al. 2004). With these observations, it 
could be possible that in pathophysiological conditions 
where K+ channel activity is altered, a transition from the 
physiological vasodilatory effect of H2O2 to a contractile 
effect may play an important role in increasing peripheral 
resistance and pathogenesis of hypertension (Cseko 
et al. 2004). In hamster gracilis muscle, Sk1/S1P was 
shown to mediate pressure-dependent myogenic tone by 
stimulating the Rac/Nox/O2
– pathway (Keller et al. 2006). 
Inhibition of a specific Nox subunit was shown to reduce 
pressure-dependent myogenic tone, but it did not affect the 
[Ca2+]i, which suggested that ROS is playing a modulatory 
rather than obligatory role in regulation of Ca2+ sensitivity 
(Keller et al. 2006). This observation is very important as 
Sk1/S1P could be a potential therapeutic target, although 
there should be a balance for the beneficial formation of 
O2
– as a physiological signalling molecule.
The role of ROS has also been investigated in diseased 
animal models. NOx2-derived O2
– may contribute to the 
enhanced myogenic response in renal afferent arterioles 
in spontaneously hypertensive rats (SHR), but not in 
normal rats (Ren et al. 2010). According to this study, the 
role of ROS is complex, because on one hand, increased 
O2
– in afferent arterioles could add to hypertension 
development. But on the other hand, after hypertension 
is established, O2
--induced myogenic enhancement could 
provide protection from glomerular barotrauma and 
injury in SHRs. In streptozotocin-induced diabetic rats, 
cerebral myogenic tone was increased in parallel with 
decreased large conductance BKCa channel activity and 
increased H2O2 (Dong et al. 2009). Rotenone, an inhibitor 
of the mitochondrial electron transport chain complex I, 
partially reversed the myogenic response, H2O2 levels 
and BKCa effect. This indicates that BKCa channels may be 
related to the inhibitory effects of rotenone on ROS (H2O2) 
production and the myogenic tone of diabetic rats (Dong 
et al. 2009). 
The important role of ROS as a signalling molecule 
in pressure-dependent myogenic tone is indisputable. 
However, there arises a significant dilemma in determining 
the borderline of the beneficial and the hazardous effect of 
ROS. Additionally, ROS members are highly diverse and able 
to elicit multiple effects within the same tissue. Paravicini 
& Sobey (2003) have highlighted the importance of the 
delicate balance between O2
– and H2O2 mediated by SOD 
when studying vascular oxidative stress. Therefore, it is 
essential to understand the exact mechanism categorized 
in order to determine how ROS can be ‘good’ or ‘bad’ 
signalling molecules. 
POTENTIAL THERAPEUTIC IMPLICATIONS OF 
ARTERIAL MYOGENIC TONE
Considering our current knowledge of myogenic tone 
regulation, an ability to adjust vascular resistance through 
specific modulation of myogenic mechanism would enable 
normal neurohormonal mechanisms to interact with the 
therapeutically treated tone. Therefore, identifying the 
primary mechanosensors in the initiation of pressure-
dependent myogenic tone is essential as these components 
could be targets for drug development. For example, in 
situations in which the cardiovascular system is depressed 
in shock and low-flow states, a drug increasing myogenic 
tone would be beneficial. On the contrary, in hyperdynamic 
conditions, reduction of drug-induced myogenic tone 
would be needed. 
The possibility of the adventitia, especially the 
adventitial fibroblast, being a potential platform for 
intravascular local drug delivery is very intriguing. 
Work in the future should focus on understanding ways 
to control adventitial fibroblast activation, to reduce 
unwanted changes in vascular structure. As the adventitial 
fibroblasts contain Nox subunits, the development of 
specific inhibitors of Nox would provide pharmacological 
tools to completely elucidate the roles of these isoforms 
in vascular physiology and pharmacology, particularly, 
in pressure-dependent myogenic tone. To date, there is 
only one such compound i.e. plumbagin that has been 
reported to inhibit Nox/O2
− production by NOx4 in cultured 
kidney embryonic cells (Ding et al. 2005). However, this 
compound was found to be carcinogenic and whether this 
compound selectively inhibits NOx4 activity or acts merely 
as a ROS scavenger was not investigated. Rey et al. (2001) 
designed a Nox inhibitor known as gp91ds-tat, which 
competitively binds to p47phox and prevents the assembly 
of the enzyme. To date, this peptide has been said to be 
the most successful Nox inhibitor because of its selectivity. 
However, it is uncertain if gp91ds-tat inhibits other Nox-
containing isoforms of Nox, such as NOX1 or NOX4. In 
conclusion, it is essential to understand the specific Nox 
subunit source of ROS within the adventitial fibroblasts as 
it may become a potential therapeutic target in treating 
vascular diseases. 
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